TMG

News

Antibody manufactured at Frederick National Laboratory receives FDA approval to treat Ebola virus disease

by TMG
Feb , 9
Antibody manufactured at Frederick National Laboratory receives FDA approval to treat Ebola virus disease

The PALM study was organized by an international research consortium coordinated by the World Health Organization and was led and funded by NIAID and the DRC’s National Institute for Biomedical Research and Ministry of Health. The consortium included the Frederick National Laboratory, Doctors Without Borders, the International Medical Corps, The Mitchell Group, and the Alliance for International Medical Action.

Post a comment

Your email address will not be published.